MODERNA IMPACT CLEARLY VISIBLE ON THE U.S. MARKET AS DOW NEARS HISTORIC 30,000-MARK

Highlights

• Moderna said its COVID-19 vaccine candidate was 94.5 percent effective against the virus and intends to submit the COVID-19 vaccine candidate for an Emergency Use Authorization (EUA) with the United States’ Food & Drug Administration (FDA)

• By jumping 1.1 percent, or 310 points, the Dow is currently 220 points below touching the 30,000-mark for the first time in its history

•....